Free Trial

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$68.90 +2.21 (+3.31%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$68.89 -0.01 (-0.01%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. MMED, TFX, HAE, ITGR, and LIVN

Should you buy Inspire Medical Systems stock or one of its competitors? Inspire Medical Systems's main competitors and comparable companies include MiniMed Group (MMED), Teleflex (TFX), Haemonetics (HAE), Integer (ITGR), and LivaNova (LIVN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspire Medical Systems compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Inspire Medical Systems (NYSE:INSP) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

In the previous week, MiniMed Group had 4 more articles in the media than Inspire Medical Systems. MarketBeat recorded 13 mentions for MiniMed Group and 9 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.25 beat MiniMed Group's score of 0.61 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiniMed Group
2 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MiniMed Group currently has a consensus target price of $24.00, indicating a potential upside of 21.77%. Inspire Medical Systems has a consensus target price of $67.29, indicating a potential downside of 2.33%. Given MiniMed Group's stronger consensus rating and higher probable upside, research analysts plainly believe MiniMed Group is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.71
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05

Inspire Medical Systems has a net margin of 15.03% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.64% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Inspire Medical Systems 15.03%8.64%7.45%

Inspire Medical Systems has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$3.10B1.79-$333M-$0.68N/A
Inspire Medical Systems$911.98M2.18$145.42M$4.6214.91

94.9% of Inspire Medical Systems shares are owned by institutional investors. 0.0% of MiniMed Group shares are owned by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Inspire Medical Systems beats MiniMed Group on 11 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Teleflex?

Teleflex (NYSE:TFX) and Inspire Medical Systems (NYSE:INSP) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

In the previous week, Inspire Medical Systems had 6 more articles in the media than Teleflex. MarketBeat recorded 9 mentions for Inspire Medical Systems and 3 mentions for Teleflex. Inspire Medical Systems' average media sentiment score of 1.25 beat Teleflex's score of 0.00 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has a net margin of 15.03% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex-39.67% 11.93% 5.44%
Inspire Medical Systems 15.03%8.64%7.45%

Inspire Medical Systems has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$1.99B2.66-$905.64M-$23.29N/A
Inspire Medical Systems$911.98M2.18$145.42M$4.6214.91

Teleflex presently has a consensus price target of $155.20, indicating a potential upside of 24.15%. Inspire Medical Systems has a consensus price target of $67.29, indicating a potential downside of 2.33%. Given Teleflex's stronger consensus rating and higher possible upside, research analysts plainly believe Teleflex is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.67
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05

Teleflex has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Teleflex beats Inspire Medical Systems on 9 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to Haemonetics?

Inspire Medical Systems (NYSE:INSP) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

Inspire Medical Systems has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Inspire Medical Systems has higher earnings, but lower revenue than Haemonetics. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.18$145.42M$4.6214.91
Haemonetics$1.33B4.05$97.31M$2.0458.26

In the previous week, Haemonetics had 10 more articles in the media than Inspire Medical Systems. MarketBeat recorded 19 mentions for Haemonetics and 9 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.25 beat Haemonetics' score of 0.52 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Haemonetics
6 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems presently has a consensus target price of $67.29, suggesting a potential downside of 2.33%. Haemonetics has a consensus target price of $110.00, suggesting a potential downside of 7.45%. Given Inspire Medical Systems' higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

Inspire Medical Systems has a net margin of 15.03% compared to Haemonetics' net margin of 7.12%. Haemonetics' return on equity of 27.55% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Haemonetics 7.12%27.55%9.65%

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 2.1% of Haemonetics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Haemonetics beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Integer?

Integer (NYSE:ITGR) and Inspire Medical Systems (NYSE:INSP) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Inspire Medical Systems has a net margin of 15.03% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.97% 12.79% 6.48%
Inspire Medical Systems 15.03%8.64%7.45%

Integer currently has a consensus target price of $109.86, suggesting a potential downside of 13.25%. Inspire Medical Systems has a consensus target price of $67.29, suggesting a potential downside of 2.33%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.07
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05

99.3% of Integer shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Integer has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

Inspire Medical Systems has lower revenue, but higher earnings than Integer. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.85B2.32$102.81M$3.6634.60
Inspire Medical Systems$911.98M2.18$145.42M$4.6214.91

In the previous week, Inspire Medical Systems had 5 more articles in the media than Integer. MarketBeat recorded 9 mentions for Inspire Medical Systems and 4 mentions for Integer. Inspire Medical Systems' average media sentiment score of 1.25 beat Integer's score of 0.27 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inspire Medical Systems beats Integer on 11 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to LivaNova?

Inspire Medical Systems (NYSE:INSP) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Inspire Medical Systems has a net margin of 15.03% compared to LivaNova's net margin of 12.82%. LivaNova's return on equity of 16.35% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
LivaNova 12.82%16.35%7.76%

Inspire Medical Systems has higher earnings, but lower revenue than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.18$145.42M$4.6214.91
LivaNova$1.39B3.03-$242.47M$3.3822.60

Inspire Medical Systems has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

Inspire Medical Systems currently has a consensus price target of $67.29, suggesting a potential downside of 2.33%. LivaNova has a consensus price target of $87.75, suggesting a potential upside of 14.87%. Given LivaNova's stronger consensus rating and higher probable upside, analysts plainly believe LivaNova is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
4 Sell rating(s)
12 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.05
LivaNova
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Inspire Medical Systems had 1 more articles in the media than LivaNova. MarketBeat recorded 9 mentions for Inspire Medical Systems and 8 mentions for LivaNova. Inspire Medical Systems' average media sentiment score of 1.25 beat LivaNova's score of 0.71 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LivaNova beats Inspire Medical Systems on 10 of the 16 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$1.99B$5.49B$7.25B$23.07B
Dividend YieldN/A1.76%2.52%3.72%
P/E Ratio14.9125.57275.2928.58
Price / Sales2.1871.61582.8520.72
Price / Cash24.0532.1176.9638.93
Price / Book2.565.9511.224.72
Net Income$145.42M$146.18M$3.50B$1.07B
7 Day Performance-2.08%-0.28%-0.89%0.35%
1 Month Performance-5.23%-2.08%-4.02%-3.40%
1 Year Performance-8.42%5.39%7.13%9.40%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
2.4947 of 5 stars
$68.90
+3.3%
$67.29
-2.3%
-8.4%$1.99B$911.98M14.911,333
MMED
MiniMed Group
2.116 of 5 stars
$20.16
+2.3%
$24.14
+19.8%
N/A$5.54B$3.10BN/A2,800
TFX
Teleflex
4.0898 of 5 stars
$125.40
+1.0%
$155.20
+23.8%
+4.6%$5.26B$1.99BN/A15,500
HAE
Haemonetics
2.2864 of 5 stars
$104.85
+0.2%
$99.78
-4.8%
+143.3%$4.76B$1.33B51.403,009
ITGR
Integer
1.9266 of 5 stars
$126.62
+0.1%
$109.86
-13.2%
+25.4%$4.30B$1.85B34.6011,000

Related Companies and Tools


This page (NYSE:INSP) was last updated on 10/11/2026 by MarketBeat.com Staff.
From Our Partners